0054-0373-25 · Lisdexamfetamine Dimesylate Capsule · Hikma Pharmaceuticals USA, Inc.
What is the status for 0054-0373-25 · Lisdexamfetamine Dimesylate Capsule · Hikma Pharmaceuticals USA, Inc.?
For 0054-0373-25, generic name is Lisdexamfetamine Dimesylate Capsule; manufacturer is Hikma Pharmaceuticals USA, Inc; status is Current; availability now is Limited Availability; fda note is Available on allocation, recorded from its source on 2026-11-04.
"initial_posting_date": "07/14/2023", "package_ndc": "0054-0373-25", "generic_name": "Lisdexamfetamine Dimesylate Capsule", "contact_info": "800-631-2174", "availability": "Limited Availability", "related_info": "Available on allocation"
— api.fda.gov, retrieved 2026-11-04
- Package NDC
- 0054-0373-25 verified
- Generic name
- Lisdexamfetamine Dimesylate Capsule verified
- Manufacturer
- Hikma Pharmaceuticals USA, Inc. verified
- Status
- Current verified
- Availability now
- Limited Availability verified
- FDA note
- Available on allocation verified
- Initial posting date
- 07/14/2023 verified
- Last update date
- 10/14/2026 verified
- Days in shortage
- 1209 our reading
- Reason for shortage
- Shortage of an active ingredient verified
- Dosage form
- Capsule verified
- Therapeutic category
- Psychiatry verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category
"update_date": "10/14/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Capsule", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0054-0373-25)", "company_name": "Hikma Pharmaceuticals USA, Inc.", "shortage_reason": "Shortage of an active ingredient", "status": "Current"
— all from api.fda.gov, retrieved 2026-11-04
Source
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000